Inhibikase Therapeutics, Inc. Business Finance Contracts & Agreements

58 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Registration Rights Agreement
Registration Rights Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2024
Securities Purchase Agreement, dated as of October 9, 2024
Purchase Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Series B-1 Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Series A-1 Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Securities Purchase Agreement, dated as of May 20, 2024
Purchase Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Warrant Amendment
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2024
Form of Series D Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Series C Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Series B Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Series A Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2024
Form of Securities Purchase Agreement
Purchase Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Warrant Agency Agreement
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Common Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Securities Purchase Agreement
Purchase Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2024
Form of Placement Agent Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2024
Form of Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2024
Form of Common Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2024
Registration Rights Agreement, dated as of January 25, 2023 (PIPE)
Registration Rights Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Securities Purchase Agreement, dated as of January 25, 2023 (PIPE)
Purchase Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2023
Securities Purchase Agreement, dated as of January 25, 2023 (Registered Direct)
Purchase Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2023
Form of Placement Agent Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Form of PIPE Common Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Form of PIPE Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Form of Private Common Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Form of Pre-Funded Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2023
Equity Distribution Agreement, dated May 16, 2022, by and between Inhibikase Therapeutics, Inc. and Piper Sandler & Co
Equity Distribution Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2022
Form of Stock Option Grant Notice and Award Agreement
Stock Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2022
Form of Representatives Warrant Agreement
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2021
Underwriting Agreement dated June 15, 2021 by and between Inhibikase Therapeutics, Inc. and ThinkEquity, a division of Fordham Financial Management, Inc., as representative of the...
Underwriting Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2021
Form of Representatives Warrant
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2021
Form of Underwriting Agreement
Underwriting Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2021
Amendment to Promissory Note by and between Inhibikase Therapeutics, Inc. and Flagship Consulting, Inc., dated October
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2020
Convertible Revolving Demand Promissory Note, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting Inc., dated April 3, 2018
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Letter Agreement to Restated Agreement to Repay Individual Loan, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner, dated September 11, 2020
Loan Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
2020
Agreement to Repay Individual Loan, by and between Inhibikase Therapeutics, Inc. and Milton H. Werner, dated February 5, 2020
Loan Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Amended and Restated Second Convertible Revolving Demand Promissory 2020 Note, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 31, 2020
Note Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
GA
2020
Warrant, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 25, 2020
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020
Warrant, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 25, 2020
Warrant Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
DE
2020